Variations in early gut microbiome are associated with childhood eczema

Area of Science:

• Microbiology
• Pediatrics
• Immunology

Background:

• Childhood eczema is a common inflammatory skin condition.
• The gut microbiome plays a crucial role in immune system development and function.
• Early-life gut microbiome alterations are increasingly implicated in allergic diseases.

Purpose of the Study:

• To investigate the association between gut microbiome composition and childhood eczema.
• To identify specific microbial taxa linked to eczema development in young children.
• To analyze age-dependent variations in the gut microbiome of infants and toddlers with eczema.

Main Methods:

• 16S rRNA gene sequencing was used to profile the gut microbiome in 172 children (aged <3 years).
• Subjects were categorized into healthy and eczema groups and further divided into four age strata.
• Quantitative PCR (qPCR) was employed for validation in the original and a separate cohort (N=57).

Main Results:

• A lower relative abundance of Bifidobacterium was significantly associated with childhood eczema.
• Decreased microbial diversity was most pronounced in eczema patients aged 2-3 years.
• Bifidobacterium showed high predictive power (AUC=0.83) for eczema and was reduced in eczema groups from 0.5 to 3 years, but not in infants <6 months.
• qPCR confirmed lower Bifidobacterium quantities in eczema groups aged 0.5-3 years.

Conclusions:

• Early-life gut microbiome dysbiosis, characterized by reduced Bifidobacterium, is associated with childhood eczema.
• Bifidobacterium appears to be a key genus involved in the pathogenesis of eczema.
• Age-specific alterations in the gut microbiome may influence eczema development in early childhood.